About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Profile
Schools
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Scientometrics
Avg Impact Factor
h-index
g-index
★★
Articles
★★★
Articles
exaly
›
Institutions
›
BC Cancer Agency
›
Top Articles
BC Cancer Agency
Canada
(bccancer.bc.ca)
10.8K
(top 3%)
articles
497.4K
(top 2%)
citations
4,149
(top 2%)
★★
articles
234
(top 2%)
★★★
articles
3.5
(top 9%)
Avg IF
277
(top 2%)
H-Index
492
(top 1%)
G-Index
1,451
journals
Most Cited Articles of BC Cancer Agency in 2017
Title
Journal
Year
Citations
Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial
Lancet, The
2017
1.2K
Integrated genomic characterization of oesophageal carcinoma
Nature
2017
965
Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer
Cell
2017
961
Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial
Lancet Oncology, The
2017
706
Association analysis identifies 65 new breast cancer risk loci
Nature
2017
643
The whole-genome landscape of medulloblastoma subtypes
Nature
2017
472
Androgen Suppression Combined with Elective Nodal and Dose Escalated Radiation Therapy (the ASCENDE-RT Trial): An Analysis of Survival Endpoints for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost to a Dose-Escalated External Beam Boost for High- and Intermediate-risk Prostate Cancer
International Journal of Radiation Oncology Biology Physics
2017
419
Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma
Cancer Cell
2017
391
Guidelines for the use of flow cytometry and cell sorting in immunological studies
European Journal of Immunology
2017
359
Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma
Cancer Cell
2017
350
Buparlisib plus fulvestrant versus placebo plus fulvestrant in postmenopausal, hormone receptor-positive, HER2-negative, advanced breast cancer (BELLE-2): a randomised, double-blind, placebo-controlled, phase 3 trial
Lancet Oncology, The
2017
330
Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial
Lancet Oncology, The
2017
328
Cancer-Associated Mutations in Endometriosis without Cancer
New England Journal of Medicine
2017
310
CIViC is a community knowledgebase for expert crowdsourcing the clinical interpretation of variants in cancer
Nature Genetics
2017
308
ABySS 2.0: resource-efficient assembly of large genomes using a Bloom filter
Genome Research
2017
305
Afatinib versus gefitinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: overall survival data from the phase IIb LUX-Lung 7 trial
Annals of Oncology
2017
296
Confirmation of ProMisE: A simple, genomics-based clinical classifier for endometrial cancer
Cancer
2017
267
CX-5461 is a DNA G-quadruplex stabilizer with selective lethality in BRCA1/2 deficient tumours
Nature Communications
2017
251
Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles
Cell Reports
2017
247
Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes
Nature Genetics
2017
246
3rd ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
Annals of Oncology
2017
241
Non-Hodgkin lymphoma
Lancet, The
2017
225
Integrated Molecular Characterization of Uterine Carcinosarcoma
Cancer Cell
2017
210
Fate mapping of human glioblastoma reveals an invariant stem cell hierarchy
Nature
2017
197
Secondary Somatic Mutations Restoring and Associated with Acquired Resistance to the PARP Inhibitor Rucaparib in High-Grade Ovarian Carcinoma
Cancer Discovery
2017
193
site/software ©
exaly
; All materials licenced under
CC by-SA
.